<?xml version="1.0" encoding="UTF-8"?>
<ref id="B86-ijms-22-00634">
 <label>86.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Twardowski</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kanaya</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Frankel</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Synold</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ruel</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Pal</surname>
    <given-names>S.K.</given-names>
   </name>
   <name>
    <surname>Junqueira</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Prajapati</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nguyen</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Tryon</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells (MDSCs) for 
   <italic>Agaricus</italic> bisporus induced PSA responses
  </article-title>
  <source>Cancer</source>
  <year>2015</year>
  <volume>121</volume>
  <fpage>2942</fpage>
  <lpage>2950</lpage>
  <pub-id pub-id-type="doi">10.1002/cncr.29421</pub-id>
  <pub-id pub-id-type="pmid">25989179</pub-id>
 </element-citation>
</ref>
